Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Biotinylated Antibody

Catalog #: FAB9576B Datasheet / COA / SDS
Recombinant Monoclonal Antibody For Research Use Only

Discontinued Product

FAB9576B has been discontinued.
View all CD30/TNFRSF8 products.
Detection of CD30/TNFRSF8 in Jurkat human acute T cell leukemia cell line by Flow Cytometry.
1 Image
Product Details
FAQs
Reviews

Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Biotinylated Antibody Summary

Species Reactivity
Human
Specificity
Detects human CD30/TNFRSF8 in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Brentuximab. This product is for research use only
Source
Recombinant Monoclonal Human IgG1 Clone # Hu8
Purification
Protein A or G purified from cell culture supernatant
Immunogen
Human CD30/TNFRSF8
Formulation
Supplied in a saline solution containing BSA and Sodium Azide.
Label
Biotin

Applications

Recommended Concentration
Sample
Flow Cytometry
10 µL/106 cells
See below

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Flow Cytometry Detection of CD30/TNFRSF8 antibody in Jurkat human acute T cell leukemia cell line antibody by Flow Cytometry. View Larger

Detection of CD30/TNFRSF8 in Jurkat human acute T cell leukemia cell line by Flow Cytometry. Jurkat human acute T cell leukemia cell line was stained with Human Anti-Human CD30/TNFRSF8 (Brentuximab Biosimilar) Biotinylated Monoclonal Antibody (Catalog # FAB9576B, filled histogram) or irrelevant biotinylated antibody (open histogram) followed by PE-conjugated Streptavidin (Catalog # F0040). View our protocol for Staining Membrane-associated Proteins.

Reconstitution Calculator

Preparation and Storage

Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Do not freeze.
  • 12 months from date of receipt, 2 to 8 °C as supplied.

Background: CD30/TNFRSF8

Brentuximab is a biosimilar directed against the extracellular domain of CD30. This biotinylated antibody can be used in flow cytometry or various assay format to measure CD30 expression and can be detected by conjugated streptavidin.

Entrez Gene IDs
943 (Human); 21941 (Mouse); 25069 (Rat)
Alternate Names
CD30 antigen; CD30; CD30KI-1; CD30L receptor; cytokine receptor CD30; D1S166EKi-1; Ki-1 antigen; Lymphocyte activation antigen CD30; TNFRSF8; tumor necrosis factor receptor superfamily member 8; tumor necrosis factor receptor superfamily, member 8

Product Datasheets

You must select a language.

x

Product Specific Notices

Brentuximab is a biosimilar expressed in Hek293 cells and is intended for research use only.

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs

Reviews for Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Biotinylated Antibody

There are currently no reviews for this product. Be the first to review Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Biotinylated Antibody and earn rewards!

Have you used Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Biotinylated Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review